5 Best High Dividend Stocks To Buy Right Now

Actionable Items:

Highest Positive Spread: ING Emerging Markets High Dividend Equity Fund (IHD)Focus Stock: Central Securities Corporation (CET)Last Week's Focus Stock: Central Securities Corporation

Junk Bonds Debacle: The $85 billion monthly bond-purchase program has produced a selloff for "junk" bonds. The U.S. Treasurys jumped 0.18% to 4.39% on Wednesday. The benchmark 10-Year Treasury note has risen 0.5% in the past month.

About $187 billion of junk bonds have been issued in the U.S. so far this year, a year-to-date record in data going back to 1995. This may be a sell-off of the "junk" bonds. The break in the pattern could mean high yield ("junk") investors may be threatened.

CEF "Junk" Bond Investors: Of the 73 CEFs of "HiYldBndFnds" it is only seven (7) CEFs without leverage. The leverage is 24% of net asset value, which will have to be leveraged again. Of "HiYldBndFnds" the premium is 0.9% and the average monthly yield is 7.2%. For the CEF industry (without HiYldBndFnds), the discount is -3.1% and the distribution yield is 6.0%.

Top 5 Growth Stocks To Buy Right Now: CommunityOne Bancorp (COB)

CommunityOne Bancorp , formerly FNB United Corp., incorporated in 1984, is a bank holding company. The Company has two banking subsidiaries: CommunityOne Bank, N.A. (CommunityOne), a national banking association, and through Bank of Granite Corporation (Granite Corp.), Bank of Granite (Granite), a state-chartered bank headquartered in Granite Falls, North Carolina. As of December 31, 2011, CommunityOne had 45 branches, $843.9 million in loans and $1.4 billion in deposits. As of December 31, 2011, Granite had 18 branches, $373.9 million in loans and $688.5 million in deposits. Through its banking subsidiaries, it offers a line of consumer, mortgage and business banking services, including loan, deposit, cash management, investment management and trust services, to individual and business customers through operations located in Alamance, Alexander, Ashe, Burke, Caldwell, Catawba, Chatham, Gaston, Guilford, Iredell, Mecklenburg, Montgomery, Moore, Orange, Randolph, Richmond, Rowan, Scotland, Watauga and Wilkes counties in North Carolina. On October 21, 2011, it acquired Granite Corp., through the merger of a wholly owned subsidiary of the Company, Gamma Merger Corporation, merging into Granite Corp, with Granite Corp. continuing as the surviving corporation and as a wholly owned subsidiary of the Company. On June 8, 2013, CommunityOne Bank, N.A., the principal bank subsidiary of FNB United Corp. announced that it had completed the merger of its sister bank, Bank of Granite, into CommunityOne.

Lending Activities

The Company's loan portfolio segments are commercial and agricultural, real estate - construction, real estate - mortgage, and consumer loans. The commercial and agricultural portfolio includes owner occupied and non-owner occupied. The real estate - construction portfolio includes retail properties, multi-family, industrial and warehouse, and other commercial real estate. The real estate - mortgage portfolio includes one-to four-family residential and commercial and othe! r. As of December 31, 2011, its total loan portfolio totaled $1.2 billion.

Investment Activities

The Company�� available-for-sale investment securities portfolio includes obligations of the United Sates treasury and government agencies, obligations of the United Sates government sponsored agencies, obligations of states and political subdivisions, residential mortgage-backed securities- (government-sponsored enterprise (GSE)), residential mortgage-backed securities-(Private), and corporate notes. As of December 31, 2011, it no longer had securities in the held-to-maturity portfolio.

Sources of Funds

Traditional deposit accounts are the primary source of funds for the Company. As of December 31, 2011, deposits totaled $2.1 billion, consisting of approximately $234.6 million of non-interest-bearing demand deposits, $349 million of interest-bearing demand deposits, $68 million of savings deposits, approximately $431.7 million of money market deposits, $112 million of brokered deposits, $538 million of time deposits less than $100,000, and $398 million of time deposits $100,000 or more. As of December 31, 2011, it had $8.8 million of total short-term borrowings. As of December 31, 2011, its long-term debt included $58 million of Federal Home Loan Bank (FHLB) advances and $56 million of junior subordinated debt. Funds are borrowed on an overnight basis through retail repurchase agreements with bank customers and federal funds purchased from other financial institutions. Retail repurchase agreement borrowings are collateralized by securities of the United Sates Treasury and the United Sates Government agencies and corporations. As of December 31, 2011, CommunityOne and Granite had no lines of credit at the Federal Reserve Bank. As of December 31, 2011, CommunityOne had an available line of credit of $80.5 million with the FHLB and Granite had no line of credit with the FHLB.

Subsidiary Activity

CommunityOne owns three subsidiari! es, which! include Dover Mortgage Company (Dover), First National Investor Services, Inc. and Premier Investment Services, Inc. (Premier). Dover ceased operations during the year ended December 31, 2011, and filed for Chapter 11 bankruptcy on February 15, 2012. First National Investor Services, Inc. holds deeds of trust for CommunityOne. Premier is inactive. Through Granite Corp., it also own Granite Mortgage, Inc., which filed for Chapter 11 bankruptcy on February 15, 2012. FNB also owns FNB United Statutory Trust I, FNB United Statutory Trust II, and Catawba Valley Capital Trust II, which were formed to facilitate the issuance of trust preferred securities.

Advisors' Opinion:

• [By Sofia Horta e Costa]

  Cobham Plc (COB), the world�� largest maker of airborne refueling kits, tumbled 4.6 percent to 272.9 pence. An investor, who was not named, was sold 39.1 million shares at 273.5 pence to market price, according to terms obtained by Bloomberg News.

• [By Namitha Jagadeesh]

  Cobham Plc (COB) retreated 4.6 percent to 272.9 pence, the biggest drop in six months. A shareholder of the world�� largest maker of airborne-refueling kit is selling 39.1 million shares in the company, terms obtained by Bloomberg News show.

5 Best High Dividend Stocks To Buy Right Now: NMI Holdings Inc (NMIHZ)

NMI Holdings, Inc. (NMIH), incorporated on May 19, 2011, is a development-stage company. The Company through its subsidiaries provides private mortgage insurance in the United States. The Company�� wholly owned subsidiaries include National Mortgage Insurance Corporation and National Mortgage Reinsurance Inc One.

On April 24, 2012, NMI Holdings, Inc. (NMI) closed an agreement with MAC Financial Ltd. to acquire MAC Financial Holdings Corporation and its wholly owned subsidiaries. On September 30, 2013, the Company merged MAC Financial Holding Corporation into NMIH, with NMIH surviving the merger, and it merged NMRI Two into NMIC, with NMIC surviving the merger.

Advisors' Opinion:

• [By Zachary Tracer]

  NMI Holdings Inc. (NMIHZ), a mortgage insurer backed by funds tied to Carlyle Group LP (CG) and Kyle Bass, filed to sell shares in an initial public offering as investors bet on a housing-market rebound.

5 Best High Dividend Stocks To Buy Right Now: Highway 50 Gold Corp (HWY)

Highway 50 Gold Corp. is an exploration-stage company. The Company is engaged principally in the acquisition and exploration of exploration and evaluation assets. The Company owns, or has the right to acquire an interest in, two projects located in Nevada (the Golden Brew Property and the Porter Canyon Project). Porter Canyon Project consists of 201 unpatented claims located in Lander County, Nevada that cover the projected north-eastern terminus of the Eastgate volcanic trough under pediment cover outboard of the Quito Mine. The Golden Brew claims (Golden Brew) consists of 153 claims prospective for Carlin-style gold mineralization. The gold mineralization at Golden Brew consists of a zone of gold bearing jasperoid measuring 2,500 feet long and up to 200 feet wide, hosted in thin bedded platey Cambrian-aged carbonates. Advisors' Opinion:

• [By Ben Levisohn]

  It wasn’t all good news, however. Healthways�(HWY) plunged 30% to $11.41, making it the S&P 1500′s biggest loser, while�Cameron International (CAM) fell 18% to $53.25, making it the S&P 500′s weakest stock. Both released disappointing earnings reports this week.

5 Best High Dividend Stocks To Buy Right Now: Valeant Pharmaceuticals International Inc(VRX)

Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products in the areas of neurology, dermatology, and branded generics. It offers Wellbutrin XL to treat depressive disorders; Xenazine to treat chorea associated with Huntington?s disease; CeraVe to rebuild and repair skin barrier; and Kinerase, a cosmetic product. The company also provides Zovirax ointment to treat initial genital herpes; Xerese to treat recurrent herpes labialis; Elidel to treat atopic dermatitis; and Acanya and Atralin gels to treat acne vulgaris. In addition, it offers Cesamet to treat nausea and vomiting associated with cancer chemotherapy; Tiazac XC to treat hypertension and angina; Wellbutrin to treat depressive illness; Sublinox to treat insomnia; and Lodalis to treat hypercholesterolemia. Further, the company provides Cold-FX to strengthen immune system; Duromine/Metermine for weight loss; Difflam to treat sore throa ts; and Duro-Tuss and Rikodeine to treat dry and chesty cough, as well as various branded generics for treatments, including antibiotics, treatments for cardiovascular and neurological diseases, antifungal medications, and diabetic therapies. Additionally, it offers Bisocard to treat hypertension and angina pectoris; Flucinar, a corticosteroid ointment; and Sachol mouth ulcer gel; Bedoyecta to treat neurotic pain; M.V.I., a hospital dietary supplement for trauma and burns; Tandene to treat fever and headache; Melleril to treat anxiety and depression; and products for therapeutic classes, such as vitamin deficiency, antibacterials, and dermatology. It markets its products in the United States, Canada, Australia, New Zealand, Europe, Latin America, southeast Asia, and South Africa. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International, Inc. in September 2010. The company was founded in 1960 and is headquartered in M ississauga, Canada.

Advisors' Opinion:

• [By Philip Springer]

  This was a big week for the global pharmaceutical industry. First, rumors of one deal suggested a possible return to the industry’s old self-destructive ways. But then two other transactions were announced that signaled continuation of a newer trend that’s much healthier for shareholders.
  
  On Monday, it was reported that New York-based Pfizer Inc. (NYSE: PFE) had been in talks to acquire AstraZeneca PLC (NYSE: AZN), headquartered in London, for over $100 billion. The companies apparently broke off the discussions.
  
  If such a transaction were to occur, it would be the latest in a long series of megamergers that characterized the corporate strategies of Pfizer, Swiss drug giant Novartis AG (NYSE: NVS) and others in the 1990s and 2000s. Back then, the aim was to acquire rivals in multibillion-dollar deals that broadened the buyers’ businesses to cover more diseases and new health-care areas.
  
  The catalyst for this buying binge was the so-called patent cliff, in which some of the sector’s biggest drugs faced the loss of patents that protected them from competition, resulting in reduced revenues and earnings.
  
  Since then, however, the patent cliff problem has waned because many of those patent expirations have already occurred. And the bigger, combined companies generally have come up short on development of new blockbuster drugs. Also, excessive diversification has brought weak competitive positions in some niches.
  
  But the current industry trend is for companies to focus more on their core strengths instead of diversifying. Pfizer, Bristol-Myers Squibb (NYSE: BMY), Johnson & Johnson (NYSE: JNJ) and Abbott Laboratories (NYSE: ABT) have made such moves over the last few years in order to focus on what they consider higher-growth prospects.
  
  Tuesday brought more of the same. Novartis and UK-based GlaxoSmithKline (NYSE: GSK) announced more than $20 billion in deals. Novartis is to sell its animal-drugs busi